HV
Insider
Hannah Valantine
DirectorHannah Valantine (Director) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in BridgeBio Pharma, Inc. (BBIO). The largest single filing was $1.7M of BBIO (25,484 sh across 2 lots, as filed), executed Feb 27.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
6
0 buys · 6 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$5.7M
shares × price, as filed
Last traded
Jul 16
Filed Jul 17
Median ADV $293.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $6.5M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
6 filings
Sector per market data · by filing · past 12 months
Most traded names
BBIORecent filings
BBIOSALE
BridgeBio Pharma, Inc.
View filing →
$419K12,875 sh × $32.58
Exec Mar 6 2025
Filed Mar 10 2025 · 5:30 PM ET